Voglistar Gm2 Tablet 10

Product Overview

Voglistar GM2 Tablet ER is a combination antidiabetic medicine specifically formulated to manage type 2 diabetes mellitus in adults. By targeting multiple pathways of blood sugar regulation, this tablet helps maintain stable glucose levels and reduces the risk of complications associated with diabetes.

It is intended for oral use and should be taken with or immediately before meals. Regular, consistent dosing as prescribed by your doctor is essential for optimal blood sugar control. Voglistar GM2 Tablet ER works best alongside a healthy diet, regular exercise, and lifestyle modifications recommended by your healthcare provider.

Key Benefits

Effective blood sugar control: Helps lower both fasting and post-meal glucose levels.

Prevents diabetes complications: Reduces the risk of kidney damage, nerve issues, eye problems, and cardiovascular events.

Triple-action formula: Combines glimepiride, metformin, and voglibose to provide better glucose management when single or dual therapies are insufficient.

Supports long-term health: Regular use with diet and exercise promotes a healthy lifestyle and reduces long-term risks.

Uses

Management of type 2 diabetes mellitus

Control of post-meal blood glucose spikes

Part of a comprehensive diabetes treatment program including diet and exercise

How to Use

Take Voglistar GM2 Tablet ER with or immediately before meals, as advised by your doctor.

Swallow the tablet whole; do not crush, chew, or break it.

Take at the same time each day to maintain consistent blood sugar control.

If you miss a dose, take it as soon as possible. Skip it if it is almost time for your next dose.

Continue therapy even if you feel well or blood sugar levels are normal.

How It Works

Voglistar GM2 Tablet ER combines three antidiabetic agents for comprehensive glucose management:

Glimepiride: A sulfonylurea that stimulates the pancreas to release more insulin, lowering blood sugar.

Metformin: A biguanide that reduces glucose production in the liver, slows absorption in the intestines, and improves insulin sensitivity.

Voglibose: An alpha-glucosidase inhibitor that delays the breakdown of complex sugars into glucose, preventing post-meal sugar spikes.

Together, these three medicines work synergistically to provide enhanced blood sugar control when single or dual therapies are insufficient.

Possible Side Effects

Most side effects are mild and self-limiting. Contact your doctor if symptoms persist or worsen.

Common side effects include:

Nausea and vomiting

Diarrhea

Abdominal pain

Loss of appetite

Hypoglycemia (low blood sugar)

Precautions: Recognize signs of low blood sugar such as sweating, dizziness, headache, and shakiness. Carry a fast-acting glucose source like fruit juice or sugar. Avoid alcohol, as it can worsen hypoglycemia.

Safety Advice

Alcohol: ❌ Unsafe – may increase risk of low blood sugar.
Pregnancy: ⚠️ Consult your doctor – limited human data; may be unsafe.
Breastfeeding: ⚠️ Consult your doctor – may pass into breast milk.
Driving: ⚠️ Caution – ability may be affected by low or high blood sugar.
Kidney: ❌ Unsafe in severe kidney disease; avoid use.
Liver: ⚠️ Use with caution in mild to moderate liver disease; avoid in severe liver disease.

Why Choose Voglistar GM2 Tablet ER

Triple-action therapy for superior glucose control

Reduces risk of diabetes-related complications

Helps manage post-meal sugar spikes

Supports long-term health and lifestyle management

Product Variants & Keywords

Voglistar GM2 Tablet ER, Voglistar Glimepiride Metformin Voglibose Tablet, Voglistar Extended Release Diabetes Tablet, Voglistar GM2 Blood Sugar Control Tablet, Voglistar GM2 Antidiabetic Combination Tablet